One step high yield synthesis of N-(3-[18F] fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane with protic solvent system

被引:0
|
作者
Lee, S. [1 ]
Oh, S. [1 ]
Chi, D. [2 ]
Kil, H. [2 ]
Kim, J. [1 ]
Moon, D. [1 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
[2] Inha Univ, Inchon, South Korea
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S174 / S174
页数:1
相关论文
共 50 条
  • [41] Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2β-carbomethoxy-3β-(4′-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter
    Chalon, S
    Hall, H
    Saba, W
    Garreau, L
    Dollé, F
    Halldin, C
    Emond, P
    Bottlaender, M
    Deloye, JB
    Helfenbein, J
    Madelmont, JC
    Bodard, S
    Mincheva, Z
    Besnard, JC
    Guilloteau, D
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (01): : 147 - 152
  • [42] Performance of compressed sensing-based iterative reconstruction for single-photon emission computed tomography from undersampled projection data: a simulation study in 123I-N-ω-fluoropropyI-2β-carbomethoxy-3β-(4-iodophenyl)nortropane imaging
    Matsutomo, Norikazu
    Fukaya, Kaoru
    Hashimoto, Takeyuki
    Yamamoto, Tomoaki
    Sato, Eisuke
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (02) : 106 - 114
  • [43] Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3
    Mahy, P
    De Bast, M
    Leveque, PH
    Gillart, J
    Labar, D
    Marchand, J
    Gregoire, V
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (09) : 1263 - 1272
  • [44] Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3
    P. Mahy
    M. De Bast
    P. H. Leveque
    J. Gillart
    D. Labar
    J. Marchand
    V. Gregoire
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 1263 - 1272
  • [45] Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells
    Page, G
    Chalon, S
    Emond, P
    Maloteaux, JM
    Hermans, E
    NEUROCHEMISTRY INTERNATIONAL, 2002, 40 (02) : 105 - 113
  • [46] Exploration of the dopamine transporter:: In vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I)
    Guilloteau, D
    Emond, P
    Baulieu, JL
    Garreau, L
    Frangin, Y
    Pourcelot, L
    Mauclaire, L
    Besnard, JC
    Chalon, S
    NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (04) : 331 - 337
  • [47] 2β-carbomethoxy-3β-(4′-chlorophenyl)-8[(E)-[F-18]4-fluorobuten-2-yl]nortropane (FBT):: Synthesis, characterization and primate imaging of a radioligand for mapping dopamine transporter (DAT) sites by PET.
    Chen, P
    Keil, R
    Votaw, JR
    Deterding, T
    Hoffman, JM
    Kilts, C
    Abak, T
    Camp, VM
    Votaw, DB
    Malveaux, E
    Goodman, MM
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 35P - 35P
  • [48] N-(3-[F-18]FLUOROPROPYL)-N-NORDIPRENORPHINE - SYNTHESIS AND CHARACTERIZATION OF A NEW AGENT FOR IMAGING OPIOID RECEPTORS WITH POSITRON EMISSION TOMOGRAPHY
    CHESIS, PL
    HWANG, DR
    WELCH, MJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (05) : 1482 - 1490
  • [49] A high yield robotic synthesis of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) and 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F] FHPG) for gene expression imaging
    Chang, C. W.
    Lin, M.
    Wu, S. Y.
    Hsieh, C. H.
    Liu, R. S.
    Wang, S. J.
    Huang, K. L.
    Chen, C. H.
    Wang, H. E.
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (01) : 57 - 63
  • [50] SYNTHESIS OF N-[4-(2′[18F]FLUOROALKOXYBENZOYL)]- AND N-(3-[123I]IODO-4-METHOXYBENZOYL)PYRROLIDIN-2-ONES AS POTENTIAL BRAIN IMAGING AGENTS
    Akula, Murthy
    Blevins, David
    Kabalka, George W.
    Osborne, Dustin
    HETEROCYCLES, 2018, 97 (02) : 1226 - 1236